InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: frrol post# 245711

Sunday, 10/21/2018 11:30:06 AM

Sunday, October 21, 2018 11:30:06 AM

Post# of 403023
As I said, speculation. But based on some noteworthy observations.

Polymedix recorded astonishing > 90% reduction of SOM in mice. Granted, it is mice we are talking. Still, the reduction was achieved with brilacidin pouch stuffed in rodential cheeks. That provides longer contact time with mucosa than any reasonable oral rinse. How are we going to do that with humans? Ask them keep big pouches in their cheeks day after day?

Hehheh... might make them look adorably cheeky... but NO.

Sticky slowly dissolving tablet a la Validive is possibility. I happen to think the best solution is to inhibit proinflammatory interleukins as early as possible via IV. Especially if it can be shown that IV once a week is sufficient.

My main point: BP has several very talented scientists at its disposal. I would be really surprised if those scientists think that the level of efficacy achieved by IPIX is the end of development process.

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News